Neutra Corp. announced the appointment of Richard C Kaufman to spearhead its new research and development projects in the nutraceuticals industry, including projects targeting the medical cannabis sector. In his new role, Dr. Kaufman, who has over 30 years of experience as an executive nutraceuticals product developer and researcher, will lead the company's efforts to develop and market the next generation of custom nutraceutical delivery systems, particularly those engineered to improve products and services in the US MMJ market.